Literature DB >> 27194901

Advances in Management of Hepatocellular Carcinoma.

Soumya Jagannath1.   

Abstract

Entities:  

Year:  2016        PMID： 27194901      PMCID： PMC4862105          DOI： 10.1016/j.jceh.2016.03.006

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  5 in total

1.  Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.

Authors:  Xiaodong Wen; Lacy Reynolds; Rohit S Mulik; Soo Young Kim; Tim Van Treuren; Liem H Nguyen; Hao Zhu; Ian R Corbin
Journal:  Gastroenterology       Date:  2015-10-17       Impact factor: 22.682

2.  Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma.

Authors:  Norie Sawada; Manami Inoue; Motoki Iwasaki; Shizuka Sasazuki; Taichi Shimazu; Taiki Yamaji; Ribeka Takachi; Yasuhito Tanaka; Masashi Mizokami; Shoichiro Tsugane
Journal:  Gastroenterology       Date:  2012-02-16       Impact factor: 22.682

3.  Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis.

Authors:  David A Bush; Jason C Smith; Jerry D Slater; Michael L Volk; Mark E Reeves; Jason Cheng; Roger Grove; Michael E de Vera
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-13       Impact factor: 7.038

4.  Cancer mortality in India: a nationally representative survey.

Authors:  Rajesh Dikshit; Prakash C Gupta; Chinthanie Ramasundarahettige; Vendhan Gajalakshmi; Lukasz Aleksandrowicz; Rajendra Badwe; Rajesh Kumar; Sandip Roy; Wilson Suraweera; Freddie Bray; Mohandas Mallath; Poonam K Singh; Dhirendra N Sinha; Arun S Shet; Hellen Gelband; Prabhat Jha
Journal:  Lancet       Date:  2012-03-28       Impact factor: 79.321

5.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245
  5 in total
  1 in total

1.  Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity.

Authors:  Liu Ying; Hu Cheng; Xu Wen Xiong; Lin Yuan; Zhang Hai Peng; Zhong Wen Wen; Liang Jian Ka; Xiao Xiao; Cai Jing; Tan Ya Qian; Gao Zhi Liang; Yan Guang Mei; Zhu Wen Bo; Peng Liang
Journal:  Oncotarget       Date:  2017-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.